SIGA — SIGA Technologies Share Price
- $427.91m
- $272.51m
- $138.72m
- 93
- 81
- 41
- 84
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 6.13 | ||
PEG Ratio (f) | 0.3 | ||
EPS Growth (f) | 25.71% | ||
Dividend Yield (f) | 9.52% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.98 | ||
Price to Tang. Book | 1.99 | ||
Price to Free Cashflow | 8.78 | ||
Price to Sales | 3.08 | ||
EV to EBITDA | 3.86 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 31.96% | ||
Return on Equity | 28.7% | ||
Operating Margin | 50.45% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 124.96 | 133.67 | 110.78 | 139.92 | 138.72 | 121.55 | 237.44 | 38.99% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | +20.03 | -49.29 | +107.4 | -13.87 | -18.64 | +153.73 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Directors
- Phillip Gomez CEO (54)
- Daniel Luckshire CFO (50)
- Robin Abrams CAD (57)
- Dennis Hruby VPR (69)
- Michael Plansky LED (71)
- James Antal IND (70)
- Jaymie Durnan IND (67)
- Julie Kane IND (62)
- Joseph Marshall IND (68)
- Julian Nemirovsky IND (37)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 28th, 1995
- Public Since
- September 9th, 1997
- No. of Shareholders
- 34
- No. of Employees
- 46
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
NASDAQ Global Market
- Shares in Issue
- 71,436,927

- Address
- 31 East 62Nd Street, NEW YORK, 10065
- Web
- https://www.siga.com/
- Phone
- +1 2126729100
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for SIGA
Q1 2025 SIGA Technologies Inc Earnings Release
SIGA Technologies Inc Annual Shareholders Meeting
Q2 2025 SIGA Technologies Inc Earnings Release
Similar to SIGA
111
NASDAQ Global Market
ADMA Biologics
NASDAQ Global Market
ANI Pharmaceuticals
NASDAQ Global Market
Aquestive Therapeutics
NASDAQ Global Market
Avadel Pharmaceuticals
NASDAQ Global Market
FAQ
As of Today at 23:14 UTC, shares in SIGA Technologies are trading at $5.99. This share price information is delayed by 15 minutes.
Shares in SIGA Technologies last closed at $5.99 and the price had moved by -29.61% over the past 365 days. In terms of relative price strength the SIGA Technologies share price has underperformed the S&P500 Index by -33.82% over the past year.
There is no consensus recommendation for this security.
Find out moreSIGA Technologies does not currently pay a dividend.
SIGA Technologies does not currently pay a dividend.
SIGA Technologies does not currently pay a dividend.
To buy shares in SIGA Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $5.99, shares in SIGA Technologies had a market capitalisation of $427.91m.
Here are the trading details for SIGA Technologies:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: SIGA
Based on an overall assessment of its quality, value and momentum SIGA Technologies is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in SIGA Technologies is $17.53. That is 192.65% above the last closing price of $5.99.
Analysts covering SIGA Technologies currently have a consensus Earnings Per Share (EPS) forecast of $0.67 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SIGA Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -4.08%.
As of the last closing price of $5.99, shares in SIGA Technologies were trading -14.99% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SIGA Technologies PE ratio based on its reported earnings over the past 12 months is 6.13. The shares last closed at $5.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SIGA Technologies' management team is headed by:
- Phillip Gomez - CEO
- Daniel Luckshire - CFO
- Robin Abrams - CAD
- Dennis Hruby - VPR
- Michael Plansky - LED
- James Antal - IND
- Jaymie Durnan - IND
- Julie Kane - IND
- Joseph Marshall - IND
- Julian Nemirovsky - IND